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Abstract
Hypocalcemia is the most common complication after total thyroidectomy. Intact parathyroid 
hormone (i-PTH) testing is a proven effective method to detect patients at risk for postoperative 
symptomatic hypocalcemia. However, there is still uncertainty as to the timing of i-PTH testing in 
a clinical setting.
Objective: This study looked into the correlation between serum i-PTH levels measured at different 
times after total thyroidectomy and the risk of symptomatic hypocalcemia.
Methods: This retrospective case series studied a group of 110 consecutive for hypocalcemia and 
intact parathyroid hormone (PTHi) levels four and twelve hours following total thyroidectomy. 
Statistical analysis was used to evaluate the performance of isolated and serial i-PTH measurements 
to determine the likelihood of symptomatic hypocalcemia.
Results: I-PTH is highly sensitive (90.3%-96.8%) and specific (77.2%-87.3%) for symptomatic 
hypocalcemia. There was no significant difference in the sensitivity levels of the tests done four 
and twelve hours after surgery or in a serial fashion. However, the 12-hour i-PTH level was more 
specific (p < 0.0007).
Conclusion: Single i-PTH testing done 12 hours after total thyroidectomy may be used as a screening 
test to detect patients at risk for symptomatic hypocalcemia.
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INTRODUCTION
Hypocalcemia is the most frequent complication 
in total thyroidectomy and affects 1.7% to 68% of the 
patients submitted to this procedure. The drop in calcium 
serum levels is usually transient and often asymptomatic, 
and correlates with permanent hypoparathyroidism in 
only 0% to 9% of the cases. However, the presence of 
symptomatic hypocalcemia may evolve to tetany, sei-
zures, and even death unless it is diagnosed early on and 
treatment is offered to the patients1-9. Some authors be-
lieve the better way to prevent the risk of hypocalcemia 
is offering calcium oral supplementation accompanied 
or not by vitamin D to all patients submitted to total 
thyroidectomy. However, this approach could mean that 
64% to 87% of the patients would be given unnecessary 
supplementation as they do not develop symptoms and 
their parathyroid hormone (PTH) levels return to nor-
mal within the week after surgery in 70% to 94% of the 
cases10,11. Additionally, hypercalcemia occurred in 4% of 
the patients given calcium supplementation and vitamin 
D after total thyroidectomy12-14.
Considering the drawbacks of compulsory 
supplementation, most services resort to clinical moni-
toring and serial serum calcium level testing to detect 
the patients with low calcium levels and symptomatic 
hypocalcemia who could benefit from calcium and vi-
tamin D supplementation. Once most patients present 
symptoms of hypocalcemia and/or significant drops in 
serum calcium starting at 48 hours after surgery, with 
symptoms peaking in as many as four days15, they 
would have to be kept in the hospital for observation. 
Thus, patients with low risk of hypocalcemia would be 
prevented from leaving the hospital after the procedure 
and hospitalization costs would increase. Intact parathy-
roid hormone (i-PTH) testing done between one and 24 
hours after thyroidectomy was recently found to be an 
effective method in the early detection of patients with 
symptomatic hypocalcemia requiring supplementation, 
thus allowing the subjects with low risk of developing 
this complication to be discharged earlier16,17. Despite 
the proven efficacy of i-PTH testing in managing total 
thyroidectomy patients, there is still no consensus as to 
the when in postoperative care i-PTH testing should be 
done and whether serial tests or tests associated with 
serum calcium levels ought to be done.
This study looked into the correlations between 
i-PTH serum levels measured at different times in 
post-thyroidectomy care and the occurrence of symptom-
atic hypocalcemia. The findings of this study and other 
publications in the literature were used to design an 
algorithm on the use of i-PTH tests in the clinical setting.
METHOD
This longitudinal cohort study enrolled 113 con-
secutive patients submitted to total thyroidectomy and 
partial to total thyroidectomy conversion procedures in 
a tertiary care teaching hospital between June of 2006 
and December of 2010. The study was registered at 
CONEP (373972) and approved by the Research Ethics 
Committee of the institution (CEP 10048).
All patients were tested for i-PTH under anes-
thetic induction four and 12 hours after surgery with 
immunometric assay Immulite 2000® (normal thresh-
old between 11 and 67 pg/mL). They were observed 
clinically for symptom onset (lip and finger extremity 
paresthesia) and signs of hypocalcemia (Chvostek and 
Trousseau). Only the subjects with symptomatic hypo-
calcemia or confirmed low calcium levels (ionic calcium 
under 1 mmol/L) were given oral calcium and vitamin D 
supplementation. The patients were informed of the risk 
of developing hypocalcemia symptoms after discharge 
and advised to seek medical help before taking the oral 
supplementation if the symptoms manifested.
Absolute i-PTH values are dichotomic (normal 
versus below normal), and thus the probability of de-
veloping hypocalcemia was estimated based on serial 
testing and tests done four and 12 hours after surgery. In 
serial testing the lower value obtained between the two 
tests was considered for risk analysis. The performance 
of the different PTH testing times as early predictors for 
hypocalcemia was rated based on their sensitivity, speci-
ficity, positive predictive values, and negative predictive 
values using McNemar’s test. Statistical data analysis was 
performed on software package SAS release 9.2 (SAS 
Institute, Inc., Cary, N.C, USA).
RESULTS
Three patients were excluded from the study as 
they had been taking alendronate and calcium supple-
ments before surgery. Sixteen (14.54%) of the 110 pa-
tients included in the study were males and 94 (85.46%) 
were females; their mean age was 48.25 years. Ninety-six 
patients (87.2%) underwent total thyroidectomy in one 
stage, while nine (8.2%) were converted from partial 
to total thyroidectomy and another five (4.6%) were 
submitted to neck dissection of the central compartment 
combined with total thyroidectomy. Pathology testing 
confirmed the presence of malignant tumors in 55 (50%) 
patients and benign disease in the remaining subjects. 
The thirty-one (28.18%) patients with symptomatic hy-
pocalcemia were grouped together and compared to the 
other 79 (71.82%) patients with normal blood calcium 
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Table 1. Statistical results.
Sensitivity Specificity PPV NPV
4-hour PTH 93.6% 78.5% 63% 96.9%
12-hour PTH 90.3% 87.3% 73.7% 95.8%
sPTH 96.8% 77.2% 62.5% 98.4%
PPV (positive predictive value); NPV (negative predictive value).
Table 2. McNemar’s test comparing 4-hour, 12-hour, and serial 
i-PTH test results.
4h PTH vs. 12h PTH 4h PTH vs. sPTH 12h PTH vs. sPTH
Sensitivity 0.936 vs. 0.903 (p = 1)
0.936 vs. 0.968 
(p = 1)
0.903 vs. 0.968 
(p = 0.5)
Specificity
0.785 vs. 0.873 
(p = 0.03)
0.785 vs. 0.772 
(p = 1)
0.873 vs. 0.772 
(p = 0.007)
The Bonferroni correction states that for multiple comparisons only 
p-values greater than 0.01 are deemed significant.
levels. The levels of i-PTH at different points in post-
operative care were highly sensitive (90.3% to 96.8%) 
for symptomatic hypocalcemia, while specificity ranged 
between 77.2% and 87.3%. No significant differences 
were found in the sensitivity level of the tests done four 
or twelve hours after surgery and in serial testing, but 
the specificity and positive to negative predictive value 
ratio of i-PTH levels measured twelve hours after surgery 
were significantly higher than on serial tests (p < 0.007). 
Statistics are summed up in Tables 1 and 2.
DISCUSSION
Parathyroid function may be compromised after 
thyroidectomy, whether by direct trauma or gland vas-
cular impairment, leading to reduced levels of circulat-
ing PTH and consequent drops in blood calcium18. Until 
recently, the detection of patients at high risk for severe 
hypocalcemia relied on the clinical observation of the 
signs and symptoms connected to the complication or 
on drops in blood calcium, usually seen 24-48 hours 
after surgery19,20. The development of specific immu-
nometric assays to verify the level of i-PTH21,22 aided 
significantly to the use of parathyroid hormone as an 
early predictor for hypocalcemia in patients submitted 
to total thyroidectomy. Due to their short half-life - 3 
to 5 minutes - drops in i-PTH can be observed imme-
diately after surgery23,24. Although many studies have 
looked into the correlations between postoperative 
i-PTH levels and risk of hypocalcemia, very few tried 
to establish the obvious resulting clinical applications, 
once test results and conclusions in these studies vary 
significantly. Immediate i-PTH levels are generally 
regarded as the test results from blood collected up 
to six hours after surgery; late i-PTH is obtained 12 
hours after surgery. This study analyzed the differences 
between immediate, late, and serial i-PTH testing in 
determining the risk of hypocalcemia. Sensitivity levels 
were 93.5%, 90.3% and 96.8% in 4-hour, 12-hour, and 
serial tests respectively.
These findings were consistent with the studies 
by Soon et al.25 (92.3%), Sywak et al.26 (90%), and To-
niato et al.27 (95.85%); these authors found that drops 
in i-PTH to levels under normal in the assay were well 
correlated with occurrence of hypocalcemia. These 
levels of sensitivity are higher than those reported by 
Scurry et al.28 (80%), Di Fabio et al.29 (76.2%), and Khafif 
et al.30 (23%); these authors, by their turn, correlated 
drops in i-PTH greater than 75%-80% from the baseline 
preoperative values as a risk factor for hypocalcemia.
These findings indicate that using the lower 
threshold for normal i-PTH levels as a reference to 
determine the risk of hypocalcemia is more sensitive 
than calculating percentage drops as proposed by some 
authors, once the prevalence of severe symptomatic 
hypocalcemia is higher in patients with subnormal 
i-PTH levels31,32. No statistically significant differences 
were found when the sensitivity levels of 4-hour, 12-
hour, and serial tests were compared, thus suggesting a 
strong correlation between the findings obtained from 
tests done at different times after surgery as shown by 
Vescan et al.33 and Grodski & Serpell24.
Observed specificity levels were 78.5% (4-hour 
PTH), 87.3% (12-hour PTH), and 77.2% (sPTH), showing 
that tests can be used safely to determine which patients 
are at a low risk of developing symptomatic hypocalce-
mia when their postoperative i-PTH levels are normal. 
The same was seen by Lam & Kerr34 in a study enroll-
ing 40 patients, in which no cases of hypocalcemia 
were observed in subjects with normal postoperative 
i-PTH levels. The chance of finding subnormal i-PTH 
levels in patients with hypocalcemia was 4.2 to 7 times 
greater than the chance of observing altered test results 
in individuals with normal calcium levels.
This allows patients at a low risk for hypocalce-
mia to be discharged within 24 hours of surgery, result-
ing in significant reductions in hospitalization costs as 
shown by Payne et al.35, in a study that revealed a cost 
reduction of approximately USD 726 per total thyroidec-
tomy patient discharged earlier based on postoperative 
i-PTH and calcium levels.
Specificity was greater in the i-PTH tests done 12 
hours after surgery (p = 0.007). Therefore, we would 
like to recommend a protocol now in use at our institution, 
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Figure 1. Single test algorithm for 12-hour i-PTH as a predictor for 
hypocalcemia - PTH - intact parathyroid hormone.
in which one i-PTH test is done to screen patients at a 
low risk of developing severe symptomatic hypocalcemia 
after total thyroidectomy as shown in Figure 1.
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